Related Articles
Oncolytic cancer therapy with a vaccinia virus strain
Efficacy and safety of second‑generation CAR T‑cell therapy in diffuse large B‑cell lymphoma: A meta‑analysis
Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma
Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP
Screening of key genes associated with R‑CHOP immunochemotherapy and construction of a prognostic risk model in diffuse large B‑cell lymphoma